Clinical Network Services (CNS) logo — Pioneering Excellence in Early Stage Clinical Trials.

Clinical Network Services (CNS)

Pioneering Excellence in Early Stage Clinical Trials.

Founded 1998 Biotechnology

General Information

Company Name Clinical Network Services (CNS)
Founded Year 1998
Industries Biotechnology
Social

Get notified when Clinical Network Services (CNS) moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Clinical Network Services (CNS)

Clinical Network Services (CNS) is a Biotechnology company based in Brisbane that specializes in managing early-stage clinical trials in Australia and New Zealand. With a strong emphasis on Phase I & II trials, CNS has over 13 years of experience managing more than 145 projects, positioning it as one of the most experienced providers in the Australian market. This track record makes CNS a preferred partner for biotech companies, both locally and internationally. CNS recognizes the financial constraints often faced by small to medium-sized biotech companies and leverages Australia's streamlined regulatory system and practical review process to facilitate rapid proof-of-concept establishment, offering time and cost savings compared to processes in the USA and Europe. This strategy allows companies to defer more complex regulatory requirements until they have stronger evidence and additional funding. In addition to its core clinical trial services, CNS also offers "BioDesk," a customized product development and regulatory planning service, enabling clients to efficiently bring their lead candidates into clinical trials and achieve their commercial objectives sooner. This, combined with their specialized focus on serving SME biotech firms, demonstrates CNS's comprehensive understanding of the commercial and scientific challenges its clients face. Overall, CNS's extensive experience, specialized focus, and comprehensive service offerings position it as a valuable partner for biotech companies seeking efficient and effective management of early-stage clinical trials.

Taxonomy: Clinical Research Organisation, Phase I Clinical Trials, Phase II Clinical Trials, Biotech Companies, Regulatory Planning, Early Stage Clinical Trials, Clinical Trial Management, Brisbane-based Company, Australian Market, New Zealand Market, Fast2First Brand, BioDesk Service, Proof-of-Concept Establishment, SME Biotech Companies

No funding data available for Clinical Network Services (CNS) yet.

Get notified when Clinical Network Services (CNS) raises funding

Clinical Network Services (CNS) Alternatives & Competitors

Clinical Network Services (CNS) vs

Your Partner in Thailand

9 employees
Health Care
Clinical Network Services (CNS) vs

Improving quality of life

312 employees
Biotechnology
Clinical Network Services (CNS) vs
PRC Clinical
PRC Clinical United States

Your Clinical Trial Deserves Trust, Leadership, Collaboration.

36 employees
Biotechnology, Health Care

FAQ About Clinical Network Services (CNS)

Pioneering Excellence in Early Stage Clinical Trials.
Clinical Network Services (CNS) was founded in 1998.
Clinical Network Services (CNS) operates in the following industries: Biotechnology.
Top alternatives and competitors to Clinical Network Services (CNS) include ACLIRES Bangkok Ltd.,, MAC Clinical Research, PRC Clinical, Mobius Medical, HiRO - Harvest Integrated Research Organization. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Clinical Network Services (CNS) and ACLIRES Bangkok Ltd., are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Clinical Network Services (CNS) and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy